↓ Skip to main content

TAK1-inhibitors are cytotoxic for multiple myeloma cells alone and in combination with melphalan

Overview of attention for article published in Oncotarget, October 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news
3 news outlets
twitter
6 X users
facebook
1 Facebook page
video
1 YouTube creator

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
8 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
TAK1-inhibitors are cytotoxic for multiple myeloma cells alone and in combination with melphalan
Published in
Oncotarget, October 2021
DOI 10.18632/oncotarget.28073
Pubmed ID
Authors

Erling Håland, Ingrid Nyhus Moen, Elias Veidal, Hanne Hella, Kristine Misund, Tobias S. Slørdahl, Kristian K. Starheim

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 8 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 25%
Other 1 13%
Student > Bachelor 1 13%
Student > Doctoral Student 1 13%
Student > Ph. D. Student 1 13%
Other 1 13%
Unknown 1 13%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 2 25%
Biochemistry, Genetics and Molecular Biology 2 25%
Chemistry 1 13%
Medicine and Dentistry 1 13%
Unknown 2 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 October 2021.
All research outputs
#1,204,974
of 23,310,485 outputs
Outputs from Oncotarget
#525
of 14,403 outputs
Outputs of similar age
#29,233
of 434,498 outputs
Outputs of similar age from Oncotarget
#13
of 65 outputs
Altmetric has tracked 23,310,485 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 14,403 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 434,498 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 65 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.